A Study Evaluating the Efficacy and Safety of Vunakizumab
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the American Academy of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Multi-Center, Randomized, Double-blinded, Placebo-controlled, Dose-ranging Study Evaluating Efficacy and Safety of Vunakizumab in Patients with Moderate-to-Severe Plaque Psoriasis
J Am Acad Dermatol 2022 Jan 10;[EPub Ahead of Print], C Zhang, K Yan, Q Diao, Q Guo, H Jin, S Yang, X Chen, T Lei, J Wu, H Yu, M Zheng, X Gao, R Sinclair, Y Zhu, Q Xu, J XuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.